37°28′43″N 122°09′03″W / 37.4787°N 122.1507°W
Company type | Public |
---|---|
Industry | Biotechnology |
Founded | 2004 |
Headquarters | , United States |
Key people |
|
Revenue | US$200.5 million (2023) |
US$−306.7 million (2023) | |
Total assets | US$1.75 billion (2023) |
Number of employees | 796 (Dec 2023) |
Website | pacb |
Footnotes / references [1] PacBio Q4 2023 results |
Pacific Biosciences of California, Inc. (aka PacBio) is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation.[2][3][failed verification] PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.[4][5]
{{cite web}}
: Missing or empty |title=
(help)[permanent dead link]